Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
5
Neutral
6
Bullish
3
Bearish
21
Neutral
6
Bullish
19
Bearish
16
Neutral
0
Bullish
16
Bearish
5
Neutral
6
Bullish
3
Bearish
5
Neutral
6
Bullish
3
Bearish
16
Neutral
0
Bullish
16
Bearish
16
Neutral
0
Bullish
16
Bearish
16
Neutral
0
Bullish
16
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Hemant Surgical Industries Limited specializes in medical equipment and supplies, focusing on renal care, cardiovascular disease, and other critical care products.
The company evolved from importing medical disposables to manufacturing a wide range of medical devices and solutions in India.
Recent strategic partnerships with global entities like JMS Co. Ltd. and SWS Hemodialysis Care Co. Ltd. bolster its international reach.
Distribution agreements expanding into markets such as the Philippines suggest aggressive global scaling and diversification.
Hemant Surgical's public listing in May 2023 raised ₹25 crore, highlighting its growth ambitions.
Healthcare Equipment & Supplies
Medical Equipment & Supplies
531 Cr
Low Risk
29.2
45.4
1.4
3.2
446.00
215.00
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
383.30 | 682 Cr | 23.34 | 3.35 | 0.00 | 14.31 | 18.03 | 8.19 | ||
388.05 | 673 Cr | 65.72 | 3.87 | 0.00 | 5.88 | 7.65 | 5.02 | ||
146.80 | 653 Cr | 13.40 | 1.56 | 0.41 | 9.14 | 10.71 | 7.45 | ||
365.00 | 531 Cr | 29.17 | 3.17 | 0.00 | 13.22 | 14.71 | 6.63 | ||
390.00 | 468 Cr | 22.85 | 3.75 | 0.00 | 16.42 | 22.13 | 15.38 | ||
344.50 | 329 Cr | 75.74 | 1.82 | 0.00 | 1.15 | 3.42 | 2.21 | ||
114.00 | 282 Cr | 31.20 | 2.84 | 0.44 | 9.10 | 12.59 | 7.84 | ||
| Median: 7 Co. | — | 365.00 | 531 Cr | 29.17 | 3.17 | 0.00 | 9.14 | 12.59 | 7.45 |
Hemant Surgical Industries Ltd (HSIL) is currently trading at 365.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Hemant Surgical Industries Limited specializes in medical equipment and supplies, focusing on renal care, cardiovascular disease, and other critical care products. The company evolved from importing medical disposables to manufacturing a wide range of medical devices and solutions in India. Recent strategic partnerships with global entities like JMS Co. Ltd. and SWS Hemodialysis Care Co. Ltd. bolster its international reach. Distribution agreements expanding into markets such as the Philippines suggest aggressive global scaling and diversification. Hemant Surgical's public listing in May 2023 raised ₹25 crore, highlighting its growth ambitions.
Over the past 52 weeks, Hemant Surgical Industries Ltd has traded between a low of ₹215.00 and a high of ₹446.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Hemant Surgical Industries Ltd has a market capitalization of approximately 530.62. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Hemant Surgical Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 29.17 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 530.62 Cr, Hemant Surgical Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Hemant Surgical Industries Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Hemant Surgical Industries Ltd is 29.17. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
